Company intelligence / Profile preview

Alertgy

Melbourne, Florida, United Statesalertgy.com ↗

Ownership: Private
Employees: ~15
Development stage: Phase 1

Overview

Alertgy has developed a proprietary non-invasive continuous glucose monitoring wristband that uses low-power RF radiation and an AI-powered analytics platform to provide real-time blood glucose readings. Unlike traditional CGMs that measure interstitial fluid, Alertgy’s device measures actual blood glucose levels. The company claims improved accuracy and user experience compared to current market offerings. Clinical validation data are not publicly detailed but the technology has won innovation awards and attracted investor interest.

Therapeutic areas: Endocrinology
Modalities: DeviceNon-pharmacological therapy (wearable sensor)AI-driven digital health platform
Industry: Physiological Monitoring

Partnerships

Not specified in public sources.

Beyond the preview

Go deeper on Alertgy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alertgy.

Explore the full profile